Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Bode

Showing results (491-500 of 548) with videos related to

Pageof 55
Sort By:
Circulation Research|February 8, 2003
Local monocyte chemoattractant protein-1 therapy increases collateral artery formation in apolipoprotein E-deficient mice but induces systemic monocytic CD11b expression, neointimal formation, and plaque progressionN van Royen, I Hoefer, M Böttinger, et al.
Gut|July 1, 1990
Sucralfate in the treatment and prevention of gastric ulcer: multicentre double blind placebo controlled studyA L Blum, H Bethge, J C Bode, et al.
Journal of Cardiovascular Pharmacology|January 1, 1995
Species-dependent pharmacodynamic effects of the selective low Km cyclic AMP phosphodiesterase III inhibitors WIN 58993 and WIN 62005R L Dundore, E D Pagani, D C Bode, et al.
BMC Medical Imaging|April 14, 2025
Location-specific pathology analysis of monopodial airways in a rabbit model of bronchopulmonary dysplasia: a proof of principle studyYannis Pfleger, Lena S C Bode, David Haberthür, et al.
Deutsche Medizinische Wochenschrift (1946)|December 12, 1986
[Therapy of stomach ulcer with sucralfate and ranitidine. A multicenter double-blind study]A L Blum, J C Bode, W Domschke, et al.
Journal of Cardiovascular Pharmacology|September 1, 1994
Pharmacologic and pharmacodynamic effects of the selective low Km cyclic AMP phosphodiesterase III inhibitors WIN 63291 and WIN 62582E D Pagani, R L Dundore, D C Bode, et al.
Circulation|October 1, 1994
Fibrin-targeted recombinant hirudin inhibits fibrin deposition on experimental clots more efficiently than recombinant hirudinC Bode, M Hudelmayer, P Mehwald, et al.
Hepatology (Baltimore, Md.)|March 1, 1984
(+)-Cyanidanol-3 in the treatment of acute viral hepatitis: a randomized controlled trialH Schomerus, K H Wiedmann, W Dölle, et al.
European Journal of Pharmacology|November 16, 1993
Zaprinast increases cyclic GMP levels in plasma and in aortic tissue of ratsR L Dundore, D M Clas, L T Wheeler, et al.
European Journal of Clinical Investigation|April 30, 2005
International multicentre trial protocol to assess the efficacy and safety of tenecteplase during cardiopulmonary resuscitation in patients with out-of-hospital cardiac arrest: the Thrombolysis in Cardiac Arrest (TROICA) StudyF Spöhr, H R Arntz, E Bluhmki, et al.
Pageof 55

Showing results (491-500 of 548) with videos related to

Sort By:
Pageof 55
Circulation Research|February 8, 2003
Local monocyte chemoattractant protein-1 therapy increases collateral artery formation in apolipoprotein E-deficient mice but induces systemic monocytic CD11b expression, neointimal formation, and plaque progressionN van Royen, I Hoefer, M Böttinger, et al.
Gut|July 1, 1990
Sucralfate in the treatment and prevention of gastric ulcer: multicentre double blind placebo controlled studyA L Blum, H Bethge, J C Bode, et al.
Journal of Cardiovascular Pharmacology|January 1, 1995
Species-dependent pharmacodynamic effects of the selective low Km cyclic AMP phosphodiesterase III inhibitors WIN 58993 and WIN 62005R L Dundore, E D Pagani, D C Bode, et al.
BMC Medical Imaging|April 14, 2025
Location-specific pathology analysis of monopodial airways in a rabbit model of bronchopulmonary dysplasia: a proof of principle studyYannis Pfleger, Lena S C Bode, David Haberthür, et al.
Deutsche Medizinische Wochenschrift (1946)|December 12, 1986
[Therapy of stomach ulcer with sucralfate and ranitidine. A multicenter double-blind study]A L Blum, J C Bode, W Domschke, et al.
Journal of Cardiovascular Pharmacology|September 1, 1994
Pharmacologic and pharmacodynamic effects of the selective low Km cyclic AMP phosphodiesterase III inhibitors WIN 63291 and WIN 62582E D Pagani, R L Dundore, D C Bode, et al.
Circulation|October 1, 1994
Fibrin-targeted recombinant hirudin inhibits fibrin deposition on experimental clots more efficiently than recombinant hirudinC Bode, M Hudelmayer, P Mehwald, et al.
Hepatology (Baltimore, Md.)|March 1, 1984
(+)-Cyanidanol-3 in the treatment of acute viral hepatitis: a randomized controlled trialH Schomerus, K H Wiedmann, W Dölle, et al.
European Journal of Pharmacology|November 16, 1993
Zaprinast increases cyclic GMP levels in plasma and in aortic tissue of ratsR L Dundore, D M Clas, L T Wheeler, et al.
European Journal of Clinical Investigation|April 30, 2005
International multicentre trial protocol to assess the efficacy and safety of tenecteplase during cardiopulmonary resuscitation in patients with out-of-hospital cardiac arrest: the Thrombolysis in Cardiac Arrest (TROICA) StudyF Spöhr, H R Arntz, E Bluhmki, et al.
Pageof 55